1-3 of 3
Anna Dahlman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies

Michelle H. Nelson, Sara Fritzell, Robert Miller, Doreen Werchau, Danielle Van Citters, Anneli Nilsson, Lynda Misher, Lill Ljung, Robert Bader, Adnan Deronic, Allison G. Chunyk, Lena Schultz, Laura A. Varas, Nadia Rose, Maria Håkansson, Jane Gross, Christina Furebring, Peter Pavlik, Anette Sundstedt, Niina Veitonmäki, Hilario J. Ramos, Anna Säll, Anna Dahlman, David Bienvenue, Laura von Schantz, Catherine J. McMahan, Maria Askmyr, Gabriela Hernandez-Hoyos, Peter Ellmark
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (1): 89–101.
https://doi.org/10.1158/1535-7163.MCT-22-0395
Published: 03 January 2023
View article titled, The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies
Open the PDF for The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies in another window
Includes: Supplementary data
Journal Articles

Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms

Michael M. Grandal, Serhiy Havrylov, Thomas T. Poulsen, Klaus Koefoed, Anna Dahlman, Gunther R. Galler, Paolo Conrotto, Sara Collins, Karsten W. Eriksen, Dafna Kaufman, George F.Vande Woude, Helle J. Jacobsen, Ivan D. Horak, Michael Kragh, Johan Lantto, Thomas Bouquin, Morag Park, Mikkel W. Pedersen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (12): 2780–2791.
https://doi.org/10.1158/1535-7163.MCT-17-0374
Published: 03 December 2017
View article titled, Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms
Open the PDF for Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms in another window
Includes: Supplementary data
Journal Articles

Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance

Mikkel W. Pedersen, Helle J. Jacobsen, Klaus Koefoed, Anna Dahlman, Ida Kjær, Thomas T. Poulsen, Per-Johan Meijer, Lars S. Nielsen, Ivan D. Horak, Johan Lantto, Michael Kragh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (3): 669–680.
https://doi.org/10.1158/1535-7163.MCT-14-0697
Published: 09 March 2015
View article titled, Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance
Open the PDF for Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance in another window
Includes: Supplementary data